Lipid Metabolism in Tumor-Infiltrating T Cells. 2021

Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

T cells recognize "foreign" antigens and induce durable humoral and cellular immune responses, which are indispensable for defending pathogens, as well as maintaining the integrity and homeostasis of tissues and organs. T cells are the major immune cell population in the tumor microenvironment which play a critical role in the antitumor immune response and cancer immune surveillance. Defective immune response of tumor-infiltrating T cells is the main cause of cancer immune evasion. The antitumor response of T cells is affected by multiple factors in the tumor microenvironment, including immunosuppressive cells, immune inhibitory cytokines, tumor-derived suppressive signals like PD-L1, immnuogenicity of tumor cells, as well as metabolic factors like hypoxia and nutrient deprivation. Abundant studies in past decades have proved the metabolic regulations of the immune response of T cells and the tumor-infiltrating T cells. In this chapter, we will discuss the regulations of the antitumor response of tumor-infiltrating T cells by lipid metabolism, which is one of the main components of metabolic regulation.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016246 Lymphocytes, Tumor-Infiltrating Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. Tumor Infiltrating Lymphocyte,Tumor-Derived Activated Cell,Tumor-Derived Activated Cells,Tumor-Infiltrating Lymphocyte,Tumor-Infiltrating Lymphocytes,Activated Cell, Tumor-Derived,Activated Cells, Tumor-Derived,Infiltrating Lymphocyte, Tumor,Infiltrating Lymphocytes, Tumor,Lymphocyte, Tumor Infiltrating,Lymphocyte, Tumor-Infiltrating,Lymphocytes, Tumor Infiltrating,Tumor Derived Activated Cell,Tumor Derived Activated Cells,Tumor Infiltrating Lymphocytes
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments

Related Publications

Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
April 2024, Biomarker research,
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
August 2023, Trends in immunology,
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
March 2022, The New England journal of medicine,
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
January 2021, Current research in immunology,
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
May 2006, Journal of immunology (Baltimore, Md. : 1950),
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
April 2009, Cancer research,
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
December 2022, Dermatologie (Heidelberg, Germany),
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
January 2021, Therapeutic advances in vaccines and immunotherapy,
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
January 2018, American journal of clinical and experimental immunology,
Shangwen He, and Ting Cai, and Juanjuan Yuan, and Xiaojun Zheng, and Wei Yang
April 2021, The Journal of experimental medicine,
Copied contents to your clipboard!